
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Cancer Epidemiology Biomarkers & Prevention, Vol 3, Issue 4 353-364, Copyright © 1994 by American Association for Cancer Research
ARTICLES |
J Russo and IH Russo
Department of Pathology, Fox Chase Cancer Center, Philadelphia, Pennsylvania 19111.
Breast cancer is one of the most frequent malignancies in women, and its incidence is increasing. No reduction in the mortality rate has resulted from advances in early diagnosis and new therapeutic modalities; therefore, new approaches to the understanding of this disease are required. The observation that, in an experimental animal model, full-term pregnancy prior to exposure to a carcinogenic agent protects the mammary gland from malignant transformation led us to study the mechanisms underlying this phenomenon. The protective effect observed after pregnancy did not depend upon gestational or lactational hyperplasia of the mammary gland, but upon structural changes induced in the mammary parenchyma by those processes. Those changes are permanent, since the protective effect is maintained after pregnancy and consists in the complete differentiation of terminal end buds to lobules. The protective effect exerted by pregnancy can be mimicked by treating young virgin rats with a single placental hormone, chorionic gonadotropin. Since the possibility of preventing breast cancer by treating young nulliparous females with hormones that mimic a fullterm pregnancy that results in complete differentiation of the gland is of practical interest to the human female population, we undertook the study of the human breast. The breast of postpubertal nulliparous women is composed of lobular structures reflecting different stages of development. Lobules type 1 (lob 1) are the most undifferentiated ones. Lobules type 2 evolve from the previous ones and have a more complex morphology, being composed of a higher number of ductular structures per lobule. They progress to lobules type 3 and 4, which are present in the pregnant and lactational periods of the mammary gland. In nulliparous women the structure most frequently found at all ages is the lob 1, whereas in parous women, lob 3 is the most frequent one. Lob 1 are considered to be the site of origin of ductal carcinoma in situ, which progresses to invasive carcinoma. Lob 2 originate lobular carcinoma and lob 3 originate adenomas, fibroadenomas, sclerosing adenosis, and apocrine cysts. These observations led us to test if the degree of lobular development influences the transformation of human breast epithelial cells exposed in vitro to chemical carcinogens. We found that primary cultures derived from breast tissues composed of lobules type 1 and 2 express phenotypes of cell transformation which were not observed in cells derived from lobules type 3.(ABSTRACT TRUNCATED AT 400 WORDS)
This article has been cited by other articles:
![]() |
C. L. Rock, S. W. Flatt, G. A. Laughlin, E. B. Gold, C. A. Thomson, L. Natarajan, L. A. Jones, B. J. Caan, M. L. Stefanick, R. A. Hajek, et al. Reproductive Steroid Hormones and Recurrence-Free Survival in Women with a History of Breast Cancer Cancer Epidemiol. Biomarkers Prev., March 1, 2008; 17(3): 614 - 620. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Micheli, E. Meneghini, G. Secreto, F. Berrino, E. Venturelli, A. Cavalleri, T. Camerini, M. G. Di Mauro, E. Cavadini, G. De Palo, et al. Plasma Testosterone and Prognosis of Postmenopausal Breast Cancer Patients J. Clin. Oncol., July 1, 2007; 25(19): 2685 - 2690. [Abstract] [Full Text] [PDF] |
||||
![]() |
W F Symmans, D J Fiterman, S K Anderson, M Ayers, R Rouzier, V Dunmire, J Stec, V Valero, N Sneige, C Albarracin, et al. A single-gene biomarker identifies breast cancers associated with immature cell type and short duration of prior breastfeeding Endocr. Relat. Cancer, December 1, 2005; 12(4): 1059 - 1069. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Rowell, D. M. Carpenter, and C. A. Lamartiniere Chemoprevention of Breast Cancer, Proteomic Discovery of Genistein Action in the Rat Mammary Gland J. Nutr., December 1, 2005; 135(12): 2953S - 2959S. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Kang, A. Akoum, P. Chapdelaine, P. Laberge, P. E. Poubelle, and M. A. Fortier Independent regulation of prostaglandins and monocyte chemoattractant protein-1 by interleukin-1{beta} and hCG in human endometrial cells Hum. Reprod., November 1, 2004; 19(11): 2465 - 2473. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Jernstrom, J. Lubinski, H. T. Lynch, P. Ghadirian, S. Neuhausen, C. Isaacs, B. L. Weber, D. Horsman, B. Rosen, W. D. Foulkes, et al. Breast-feeding and the Risk of Breast Cancer in BRCA1 and BRCA2 Mutation Carriers J Natl Cancer Inst, July 21, 2004; 96(14): 1094 - 1098. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. C. Rowlands, R. Hakkak, M. J. J. Ronis, and T. M. Badger Altered Mammary Gland Differentiation and Progesterone Receptor Expression in Rats Fed Soy and Whey Proteins Toxicol. Sci., November 1, 2002; 70(1): 40 - 45. [Abstract] [Full Text] [PDF] |
||||
![]() |
Z. Jin and R. S. MacDonald Soy Isoflavones Increase Latency of Spontaneous Mammary Tumors in Mice J. Nutr., October 1, 2002; 132(10): 3186 - 3190. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. A. Britton, M. D. Gammon, J. B. Schoenberg, J. L. Stanford, R. J. Coates, C. A. Swanson, N. Potischman, K. E. Malone, D. J. Brogan, J. R. Daling, et al. Risk of Breast Cancer Classified by Joint Estrogen Receptor and Progesterone Receptor Status among Women 20-44 Years of Age Am. J. Epidemiol., September 15, 2002; 156(6): 507 - 516. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. J. Swerdlow, B. L. De Stavola, B. Floderus, N. V. Holm, J. Kaprio, P. K. Verkasalo, and T. Mack Risk Factors for Breast Cancer at Young Ages in Twins: An International Population-Based Study J Natl Cancer Inst, August 21, 2002; 94(16): 1238 - 1246. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. A. Wood, J. E. Korkola, and M. C. Archer Tissue-specific resistance to cancer development in the rat: phenotypes of tumor-modifier genes Carcinogenesis, January 1, 2002; 23(1): 1 - 9. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Tryggvadottir, H. Tulinius, J. E. Eyfjord, and T. Sigurvinsson Breastfeeding and Reduced Risk of Breast Cancer in an Icelandic Cohort Study Am. J. Epidemiol., July 1, 2001; 154(1): 37 - 42. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Yoshida, H. Eguchi, K. Nakachi, K. Tanimoto, Y. Higashi, K. Suemasu, Y. Iino, Y. Morishita, and S.-i. Hayashi Distinct mechanisms of loss of estrogen receptor {{alpha}} gene expression in human breast cancer: methylation of the gene and alteration of trans-acting factors Carcinogenesis, December 1, 2000; 21(12): 2193 - 2201. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Davis, C. Kennedy, Y.-E. Chiew, C. L. Clarke, and A. deFazio Histone Deacetylase Inhibitors Decrease Proliferation and Modulate Cell Cycle Gene Expression in Normal Mammary Epithelial Cells Clin. Cancer Res., November 1, 2000; 6(11): 4334 - 4342. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Russo, Y.-F. Hu, X. Yang, and I. H. Russo Chapter 1: Developmental, Cellular, and Molecular Basis of Human Breast Cancer J Natl Cancer Inst Monographs, July 1, 2000; 2000(27): 17 - 37. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. K. Manna, A. Mukhopadhyay, and B. B. Aggarwal Human Chorionic Gonadotropin Suppresses Activation of Nuclear Transcription Factor-kappa B and Activator Protein-1 Induced by Tumor Necrosis Factor J. Biol. Chem., April 28, 2000; 275(18): 13307 - 13314. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Lipworth, L. R. Bailey, and D. Trichopoulos History of Breast-Feeding in Relation to Breast Cancer Risk: a Review of the Epidemiologic Literature J Natl Cancer Inst, February 16, 2000; 92(4): 302 - 312. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. M. Gertig, I. E. Stillman, C. Byrne, D. Spiegelman, S. J. Schnitt, J. L. Connolly, G. A. Colditz, and D. J. Hunter Association of Age and Reproductive Factors with Benign Breast Tissue Composition Cancer Epidemiol. Biomarkers Prev., October 1, 1999; 8(10): 873 - 879. [Abstract] [Full Text] |
||||
![]() |
A. Szarewski, H. C Kitchener, J. Horowitz, C. Kahlenborn, E. C G Grant, C M. Steel, E. H Price, H. M Anthony, D. Downing, M. J Radcliffe, et al. Mortality associated with oral contraceptive use BMJ, August 7, 1999; 319(7206): 386 - 386. [Full Text] |
||||
![]() |
J. Yang, K. Yoshizawa, S. Nandi, and A. Tsubura Protective effects of pregnancy and lactation against N-methyl-N-nitrosourea-induced mammary carcinomas in female Lewis rats Carcinogenesis, April 1, 1999; 20(4): 623 - 628. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Lopez-Otin and E. P. Diamandis Breast and Prostate Cancer: An Analysis of Common Epidemiological, Genetic, and Biochemical Features Endocr. Rev., August 1, 1998; 19(4): 365 - 396. [Abstract] [Full Text] [PDF] |
||||
![]() |
Z Nikolova, V Djonov, G Zuercher, A. Andres, and A Ziemiecki Cell-type specific and estrogen dependent expression of the receptor tyrosine kinase EphB4 and its ligand ephrin-B2 during mammary gland morphogenesis J. Cell Sci., January 9, 1998; 111(18): 2741 - 2751. [Abstract] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Cancer Research | Clinical Cancer Research |
| Cancer Epidemiology Biomarkers & Prevention | Molecular Cancer Therapeutics |
| Molecular Cancer Research | Cancer Prevention Research |
| Cancer Prevention Journals Portal | Cancer Reviews Online |
| Annual Meeting Education Book | Meeting Abstracts Online |